Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000604763 | SCV000711813 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Ala401Val in exon 19 of COL4A4: This variant is not expected to have clinical significance because it has been identified in 2.02% (333/16454) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs199581317). |
Labcorp Genetics |
RCV000916224 | SCV001061457 | benign | not provided | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001138497 | SCV001298556 | likely benign | Alport syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Gene |
RCV000916224 | SCV001752980 | benign | not provided | 2020-03-06 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294355 | SCV002587515 | likely benign | Kidney disorder | 2020-07-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001138497 | SCV001464045 | benign | Alport syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |